Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ICON PUBLIC LIMITED COMPANY

(ICLR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/19/2021 11/22/2021 11/23/2021 11/24/2021 11/26/2021 Date
286.2(c) 281.53(c) 273.97(c) 273.87(c) 272(c) Last
364 383 453 668 523 792 476 428 194 721 Volume
+0.81% -1.63% -2.69% -0.04% -0.68% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 5 495 M - -
Net income 2021 282 M - -
Net Debt 2021 4 973 M - -
P/E ratio 2021 67,7x
Yield 2021 -
Sales 2022 7 950 M - -
Net income 2022 622 M - -
Net Debt 2022 3 954 M - -
P/E ratio 2022 37,4x
Yield 2022 -
Capitalization 22 140 M 22 140 M -
EV / Sales 2021 4,93x
EV / Sales 2022 3,28x
Nbr of Employees 37 960
Free-Float 99,2%
More Financials
Company
ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its... 
Sector
Biotechnology & Medical Research
Calendar
12/01 | 12:10pmPresentation
More about the company
Ratings of ICON Public Limited Company
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about ICON PUBLIC LIMITED COMPANY
11/22ICON PUBLIC : Releases Environmental, Social and Governance Report - Form 6-K
PU
11/22ICON Releases Environmental, Social and Governance Report
AQ
11/16Deutsche Bank Adjusts ICON's Price Target to $287 From $234, Maintains Hold Rating
MT
11/10ICON Announces the Expansion of its Accellacare Site Network
BU
11/10ICON Announces the Expansion of Its Accellacare Site Network
CI
11/08ICON plc to Present at the 30th Annual Credit Suisse Healthcare Conference and the 4th ..
AQ
11/05ICON plc to Present at the 30th Annual Credit Suisse Healthcare Conference and the 4th ..
PU
11/05ICON plc to Present at the 30th Annual Credit Suisse Healthcare Conference and the 4th ..
BU
11/04ICON reports third quarter 2021 financial results
AQ
11/03Q3 2021 Earnings Call Slides FINAL.pdf
PU
11/03ICON Reports Third Quarter 2021 Results - Form 6-K
PU
11/03ICON PLC : Q3 Earnings Snapshot
AQ
11/03ICON Public Limited Company Reports Earnings Results for the Third Quarter and Nine Mon..
CI
11/03Earnings Flash (ICLR) ICON Posts Q3 Revenue $1.87B
MT
11/03Earnings Flash (ICLR) ICON Posts Q3 EPS $2.55
MT
More news
News in other languages on ICON PUBLIC LIMITED COMPANY
11/03Earnings Flash (ICLR) ICON affiche un chiffre d'affaires de 1,87 milliard de dollars au..
11/03ICON Public Limited Company révise ses prévisions de bénéfices pour l'ensemble de l'ann..
02/24MÄRKTE USA/Wall Street mit deutlichen Aufschlägen - Nasdaq +1,0%
02/24ICON PUBLIC : compra PRA Health en 12.000 millones dólares, busca crecer en sector pruebas..
02/24MÄRKTE USA/Börsen mit Aufschlägen - auch Nasdaq im Plus
More news
Analyst Recommendations on ICON PUBLIC LIMITED COMPANY
More recommendations
Chart ICON PUBLIC LIMITED COMPANY
Duration : Period :
ICON Public Limited Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ICON PUBLIC LIMITED COMPANY
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 272,00 $
Average target price 303,73 $
Spread / Average Target 11,7%
EPS Revisions
Managers and Directors
Stephen A. Cutler Chief Executive Officer & Executive Director
Brendan Brennan Chief Financial Officer
Ciaran Murray Executive Chairman
Tom O'Leary Chief Information Officer
Gregory P. Licholai Chief Medical & Innovation Officer
Sector and Competitors
1st jan.Capi. (M$)
ICON PUBLIC LIMITED COMPANY39.50%22 140
MODERNA, INC.215.53%133 648
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.39%24 431